EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Repositioning Antimicrobial Peptides Against WHO‐Priority Fungi

Cesar Augusto Roque-Borda iD, Kaila Petronila Medina-Alarcón, João Paulo Soler Gonçalves Pereira, Thais Cristina Dos Anjos Sevilhano, Brigitte Aguilar-Morón, Fernando Díaz-Cárdenas, Lucas Silva da Cruz, Francisco Humberto Xavier-Júnior, Eduardo Festozo Vicente, João Perdigão, Beatriz G de la Torre, Fernando Albericio und 1 weitere

Advanced Science · 2025-10 · 12 (37)

DOI: 10.1002/advs.202509567 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 30.08.2025. Verfasst von Cesar Augusto Roque-Borda und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, School of Pharmaceutical Sciences, Universidade Estadual Paulista (UNESP), Araraquara, 14800-903, Brazil. Hauptthemen laut MEDLINE: Antimicrobial Peptides, Antifungal Agents, Drug Repositioning, Fungi. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 370 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: São Paulo Research Foundation, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES), Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The growing threat of fungal infections, particularly in immunocompromised individuals, is exacerbated by the limited number of antifungal drug classes, increasing resistance rates, and complex hostpathogen interactions. In response to this public health concern, the World Health Organization published its first list of fungal priority pathogens, including C. auris, A. fumigatus, C. neoformans, and C. albicans. These species exhibit multidrug resistance, virulence plasticity, and enhanced biofilm‐forming capacity, which contributes to antifungal tolerance and complicates treatment outcomes. Antimicrobial peptides (AMPs) have emerged as promising alternatives due to their broad‐spectrum activity, rapid membrane‐disrupting mechanisms, and low propensity to induce resistance. This review provides an in‐depth analysis of AMP‐based antifungal strategies, integrating insights from structureactivity relationships, molecular engineering, and targeted delivery systems. Strategies such as peptide hybridization, cyclization, PEGylation, and nanoparticle conjugation are examined to enhance stability, specificity, and pharmacokinetics. Opportunities for rational AMP design are also discussed, leveraging computational toolsincluding machine learning and deep learning approachesalongside immunoproteomic targeting. Together, these multidisciplinary advances underscore the potential of AMPs as next‐generation therapeutics against critical fungal pathogens. Nonetheless, clinical translation remains challenging, requiring continued investment in formulation science, regulatory alignment, and translational development pipelines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antimicrobial PeptidesAntifungal AgentsDrug RepositioningFungiMycosesHumansWorld Health Organization

Stichwörter der Autor:innen

antimicrobial peptidesfungal infectionsmultidrug‐resistant fungitarget delivery

Substanzen

Antimicrobial PeptidesAntifungal Agents

Autor:innen und Institutionen

  • Department of Biological Sciences, School of Pharmaceutical Sciences, Universidade Estadual Paulista (UNESP), Araraquara, 14800-903, Brazil.
  • iMed.ULisboa-Institute for Medicines Research, Faculty of Pharmacy, University of Lisbon, Lisbon, 1649004, Portugal.
  • Department of Clinical Analysis, School of Pharmaceutical Sciences, Universidade Estadual Paulista (UNESP), Araraquara, 14800-903, Brazil.
  • School of Sciences and Engineering, São Paulo State University (UNESP), Tupã, 17602-496, Brazil.
  • Vicerrectorado de Investigación, Universidad Católica de Santa María, Arequipa, 04000, Peru.
  • Laboratory of Pharmaceutical Biotechnology (BioTecFarm), Department of Pharmaceutical Sciences, Federal University of Paraiba, Campus Universitário I, Castelo Branco III. Cidade Universitária. CEP, João Pessoa-PB, 58051…

ORCID-Profile: Cesar Augusto Roque-Borda

Förderung

  • São Paulo Research Foundation
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES)
  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Zitieren

APA

Roque-Borda, C. A., Medina-Alarcón, K. P., Gonçalves Pereira, J. P. S., Sevilhano, T. C. D. A., Aguilar-Morón, B., Díaz-Cárdenas, F., da Cruz, L. S., Xavier-Júnior, F. H., Vicente, E. F., Perdigão, J., de la Torre, B. G., Albericio, F., & Pavan, F. R. (2025). Repositioning Antimicrobial Peptides Against WHO‐Priority Fungi. Advanced Science, 12(37). https://doi.org/10.1002/advs.202509567

Vancouver

Roque-Borda CA, Medina-Alarcón KP, Gonçalves Pereira JPS, Sevilhano TCDA, Aguilar-Morón B, Díaz-Cárdenas F, et al. Repositioning Antimicrobial Peptides Against WHO‐Priority Fungi. Advanced Science. 2025;12(37). doi:10.1002/advs.202509567

BibTeX
@article{RoqueBorda2025,
  author = {Roque-Borda, Cesar Augusto and Medina-Alarcón, Kaila Petronila and Gonçalves Pereira, João Paulo Soler and Sevilhano, Thais Cristina Dos Anjos and Aguilar-Morón, Brigitte and Díaz-Cárdenas, Fernando and da Cruz, Lucas Silva and Xavier-Júnior, Francisco Humberto and Vicente, Eduardo Festozo and Perdigão, João and de la Torre, Beatriz G and Albericio, Fernando and Pavan, Fernando Rogério},
  title = {Repositioning Antimicrobial Peptides Against WHO‐Priority Fungi},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {37},
  doi = {10.1002/advs.202509567}
}
Kostenlos starten →